oral tirzepatide fda approved approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Medical Weight Loss GLP-1 in

Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

Generic semaglutide versions are expected in India from 2026 onwards after Novo Nordisks patent expires

None of the drugs yet have clinical trials with more than 2-year follow-up which leaves us with questions as to micronutrient deficiencies and risk of loss of muscle mass and bone density

Hormone Replacement Therapy may help with hair loss when thinning is linked to low estrogen, progesterone, or testosterone imbalance

Clinical Consultations: The time spent with your provider to manage your dosage and side effects

Briefly, aliquots of 250 L were taken of each urine culture and diluted with pure methanol (1:3 for clinical samples and 1:6 for the in vitro analysis), vortexed, incubated on ice for 30 min, and centrifuged at x16000 g for 10 min